Cardlytics EBIT

Cardlytics (CDLX) currently reports a EBIT of $-29M as of March 2026. That compares with $-35M in the prior-year period — up 17.0% year over year. That is below the Consumer Discretionary sector average of $140B. Use the charts on this page to explore Cardlytics's EBIT history and peer comparisons.

Cardlytics's EBIT increased from $-35M to $-29M — a 17.0% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cardlytics's EBIT of $-29M is lower than the Consumer Discretionary sector average of $140B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Cardlytics reported $-29M in EBIT as of March 2026. That compares with $-35M in the prior-year period — up 17.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-29M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Consumer Discretionary average is $140B. From there, open related valuation or income-statement pages for Cardlytics, and consider following CDLX for alerts when major investors trade the stock.